Position in VTRS
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$203,744
+$23,917 QoQ
Shares Held
15,081
+4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Chicago Partners Investment Group LLC holds $3,214,780 across 10 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
7,389 | $973,426 | |
| 2 | ZTS |
Zoetis Inc.
|
6,340 | $749,451 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,159 | $687,263 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
13,887 | $332,315 | |
| 5 | VTRS |
Viatris Inc
This page
|
15,081 | $203,744 | |
| 6 | EOLS |
Evolus, Inc.
|
19,291 | $79,286 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
13,493 | $78,259 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
18,483 | $64,875 |
All Filings in VTRS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $203,744 | 15,081 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $179,827 | 14,444 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $125,898 | 12,717 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $120,367 | 13,479 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $94,512 | 10,851 | Shares | Sole | 2025-05-09 | |
| 2024-03-31 | $140,677 | 11,782 | Shares | Sole | 2024-04-25 | |
| No filing history on record for this holder in this stock. | ||||||